Somerset, NJ, Jan 05, 2021 – WhizAI, the first and only augmented consumer platform purpose-built for the life sciences industry, today announced Angela Losacco has joined as Senior Vice President of Global Sales. She will lead WhizAI in rapidly growing and scaling the North American and European sales teams, developing and executing strategies to accelerate revenue growth and expanding WhizAI’s increasing base of top pharmaceutical customers.
“Angela is an outstanding addition to the WhizAI team and brings a wealth of experience with early-stage software and technology companies experiencing explosive growth,” said Rohit Vashisht, Chief Executive Officer, WhizAI. “As WhizAI continues its expansion across North America and Europe, Angela’s sales leadership and her strong background in building top-performing sales teams will further accelerate our growth. We are thrilled to have her on the team.”
Angela brings over 20 years of sales and leadership experience to WhizAI. She is adept at driving revenue growth, improving sales team performance, building a new business, forging strong relationships, and securing customer loyalty. Angela is a dynamic, entrepreneurial sales and business development strategist with a record of achievement and demonstrated success in data management and analytics platforms. Before joining WhizAi, Angela was the Vice President of Sales with Collibra, where she was responsible for driving revenue growth of 50% year over year in North America.
“I am energized to join the WhizAI team as we bring the future of analytics to life sciences by putting actionable insights directly into the hands of business users,” said Angela Losacco, SVP of Global Sales, WhizAI. “WhizAI is perfectly positioned to shift the analytics power to the decision-maker by applying its augmented capabilities to the life sciences domain and in the process give end-users the tools they need to find data and generate insights on their own.” To learn more, please visit www.whiz.ai.
About WhizAI: WhizAI is the first and only augmented consumer platform purpose-built for the life sciences industry. It puts insights directly into the hands of business users empowering decision-makers to drive more informed and faster business decisions at a lower cost. With its deep understanding of the life sciences domain and user intent, the platform delivers insights without the delays of traditional BI dashboards. Fast, easy, and scalable, WhizAI is transforming analytics with artificial intelligence optimized for life sciences making WhizAI the trusted partner of choice at top global life sciences companies. Learn more about www.whiz.ai.
People also viewed
Customer Centricity and Digital Experiences which are Redefining Pharma
It is no secret that the pharmaceutical industry has historically flourished from blockbuster products with substantial brand equity, favorable pricing
Awash in Data, Yet Starving for Insights? Transform Life Sciences Commercial Teams with Augmented Analytics
Personalized communication is something the HCPs have come to expect. To do that, pharma sales reps need to know their customers well. In order to know the customer well, they need data. Enterprise pharma companies, however, have many data resources and lots of data at their disposal. In fact, there is a data explosion. So what do you do?
Readiness of Augmented Analytics for Life Sciences Commercial Teams
Demand for smart, agile, and near-instant commercial analytics in Pharma is rising. More contextual, continuous, and connected data and analytics are required to respond to more complex and uncertain business decisions.
Adding Up Data Analytics Total Cost of Ownership (TCO) and How to Lower It
High data analytics expenditures don’t have to be a cost of doing business for life sciences companies. WhizAI lowers total cost of ownership (TCO) while making data insights more accessible to business users. Traditionally, data analytics TCO has been a significant expense for life sciences organizations.
Transforming Life Sciences Commercial Function with AI and Augmented Analytics
In this whitepaper, sponsored by WhizAl, Everest Group explores the business case and profound impact Al and Augmented Analytics can have on the life sciences commercial function across various use cases in Sales, Marketing, and Market Access. They examine what top pharma enterprises are looking for in an augmented analytics tool, a roadmap for how to get started, and a blueprint for adoption.
Augmented Analytics is “On the Rise” on Gartner’s 2022 Hype Cycle for Life Science Commercial Operations
The Gartner® 2022 Hype Cycle™ for Life Science Commercial Operations introduces a new category, Augmented Analytics, this year. WhizAI is listed as a sample vendor in the Augmented Analytics category in this Hype Cycle. This summary report covers the following highlights.
Why Domain Expertise Is Essential for Life Science Analytics
Domain expertise matters. Consider this: Enterprises choose transportation and logistics companies that have created the specific types of services they need. Businesses seek professional services with experience in their industries and look for consultants with good track records in their markets. However, remember that domain expertise benefits extend to analytics platforms, particularly those deployed for life sciences.